Effect of recombinant human growth hormone on the immune function and prognosis in patients with liver neoplasms
- VernacularTitle:生长激素对肝癌切除后患者免疫功能及预后的影响
- Author:
Ya GUO
;
Minhao PENG
;
Lequn LI
;
- Publication Type:Journal Article
- Keywords:
LIVER NEOPLASMS/surg;
HEPATECTOMY/adv eff;
GROWTH HORMONE/pharm;
IMMUNE FUNENON
- From:
Chinese Journal of General Surgery
1993;0(03):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the long-term effect of recombinate human growth hormone(rhGH) on the immune function in patients with liver cancer. Methods Fifty patients with hepatoma who underwent hepatectomy were randomly divided into two groups:(1)Control group;(2)rhGH treatment(GH) group. All patients were treated with TPN for five days postoperatively,and additionally the patients in the GH group received rhGH(8U/d IH) in the evening for seven days. Results IgG,IgM,CD3,CD4 in the control group and CD8 in the GH group were significantly lower on day 10 postoperatively than that on preoperative days. IgG in the GH group significantly increased on day 15. The 1 year and 3 year survival rate and recurrent rate were not different between the two groups. Conclusions rhGH therapy can improve the immune function of patients with hepatoma who underwent hepatectomy and has no side effect on the long term survival and recurrence.
